- Home
- BWFG vs LCTX Comparison
BWFG vs LCTX Comparison
Compare BWFG & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BWFG | LCTX |
|---|---|---|
| Founded | 2002 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.5M | 388.6M |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BWFG | LCTX |
|---|---|---|
| Price | $51.53 | $1.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $55.00 | $6.25 |
| AVG Volume (30 Days) | 26.4K | ★ 1.2M |
| Earning Date | 04-22-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 261.79 | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | $2,826,000.00 | ★ $14,556,000.00 |
| Revenue This Year | $17.64 | $109.40 |
| Revenue Next Year | $6.21 | N/A |
| P/E Ratio | $36.46 | ★ N/A |
| Revenue Growth | 43.96 | ★ 53.24 |
| 52 Week Low | $34.20 | $0.65 |
| 52 Week High | $53.86 | $2.09 |
Technical Indicators
Market Signals| Indicator | BWFG | LCTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 34.20 |
| Support Level | $50.15 | $1.14 |
| Resistance Level | $53.50 | $1.31 |
| Average True Range (ATR) | 1.03 | 0.07 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 52.31 | 5.71 |
Price Performance
Historical ComparisonAbout BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.